---
title: Locemia Solutions acquired by Eli Lilly and Company
description: Locemia Solutions acquired by Eli Lilly and Company | Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).
image: https://www.covllc.com/hubfs/Locemia-Solutions.jpg
---

[![covington-logo-horizontal (1)-1](https://www.covllc.com/hubfs/covington-logo-horizontal%20(1)-1.png)](https://www.covllc.com/)

![](https://f.hubspotusercontent30.net/hubfs/3397234/logo-4.png)

![Covington Associates Announces Advisory Role in the Sale of United Rheumatology to Specialty Networks](https://www.covllc.com/hubfs/UR%20-%20Specialty%20Networks.jpg)

RECENT POST

Oct 6, 2022 12:52:23 PM |  

[Press Release](https://www.covllc.com/blog/tag/press-release)

### Covington Associates Announces Advisory Role in the Sale of United Rheumatology to Specialty Networks

[View News](https://www.covllc.com/blog/united-rheumatology-specialty-networks)

Oct 12, 2015 6:38:00 AM |  

[Covington Associates](https://www.covllc.com/blog/tag/covington-associates)

# Locemia Solutions acquired by Eli Lilly and Company

---

Covington advised Locemia Solutions on the sale of worldwide rights to Locemia’s intranasal glucagon to Eli Lilly and Company (NYSE:LLY).

##### HCD divested their Medicare Diabetes assets to U.S. Medical Supply [Next](https://www.covllc.com/blog/hcd-divested-their-medicare-diabetes-assets-to-u.s.-medical-supply)

## Get updates on news, events, and opportunities.

#### Quick Links

#### Our Transactions

#### Get in touch

** **

 99 Summer Street, Suite 200 Boston, Massachusetts 02110

617-314-3950 

[![footer-linkedin](https://www.covllc.com/hubfs/footer-linkedin.png) ](https://www.linkedin.com/company/covington-associates)

 Broker Dealer Services  
Provided Through Covington Associates, LLC. Member FINRA/SIPC.

![](https://www.covllc.com/hubfs/footer-logo%20(1).png)

 © 2026 Covington Associates All Rights Reserved.